What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its glucose monitoring system.
Trump doubled down on plans to soon impose "major" pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter.
Pete Hynes, 40, went for a 'lie down' one Saturday morning in December 2022 after suffering a sudden earache, which he put down to a cold that had struck the rest of the family.
Novo Nordisk's weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom received a warning letter from FDA.
Neil Morris, 44, from Abingdon, Oxfordshire, had just cycled 100km in November 2023 and 'didn't think anything' of some minor tightness in his neck and chest, putting it down to heartburn.
Robert F. Kennedy Jr. is making moves that could affect immunization uptake and policy in the U.S., while Oracle submits a formal application to join TEFCA.